Sena Matrevi
Dados Biográficos
| ID | 10240599 |
|---|---|
| NOME | Sena Matrevi |
| PRENOMES | Sena |
| SOBRENOME | Matrevi |
| ASSINATURA | MATREVI S |
| AFILIAÇÕES | Noguchi Memorial Institute for Medical Research |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2026 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023
Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…
Sem obras proeminentes nesta página.
Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023
Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…
Clinical trial (1 obras) · Combination therapy (1 obras) · Diverse Scientific Research Studies (1 obras) · Malaria (1 obras) · Malaria Research and Control (1 obras) · Pharmaceutical Quality and Counterfeiting (1 obras) · Plasmodium falciparum (1 obras) · Protozoal disease (1 obras)